Dr Shehzahdi Moonshi
Researcher biography
Dr Shehzahdi (Sheb) Moonshi is a nanobiologist and translational immunology researcher at the University of Queensland's Frazer Institute and Translational Research Institute (TRI). Her research focuses on developing antigen-specific immunotherapies (ASI) and nanoparticle-based precision medicines to treat autoimmune diseases such as psoriatic arthritis and rheumatoid arthritis.
At TRI (2025), she has translated this skillset to optimise antigen-specific liposomal nanotherapies for in vitro stability and evaluate their biodistribution and efficacy in vivo using preclinical models of autoimmune disease. She has also developed unique expertise in creating scalable, immune-targeted delivery platforms for clinical translation through close collaboration with a Clinical Drug Manufacturing Organisation for the scale-up and manufacture of ASITI-RA, a rheumatoid arthritis antigen-specific immunotherapy.
Her broader expertise spans:
-
Nanomedicine formulation and characterisation
-
Translational immunology and preclinical model development (humanised mice)
-
Collaborative, consumer-partnered, and clinician-led translational research
Dr Moonshi's goal is to advance precision immunotherapies that restore immune tolerance and transform outcomes for people with autoimmune and inflammatory diseases.